IL283561B
(en )
2022-01-01
Methods for treating ocular diseases
IL279308A
(en )
2021-01-31
Methods for treating hepcidin-mediated disorders
EP3500289A4
(en )
2020-05-06
Methods for treating tracheobronchomalacia
EP3265053A4
(en )
2018-08-08
Methods for treating skin
EP3157463A4
(en )
2018-02-21
Methods and devices for treating posterior ocular disorders
EP3283655A4
(en )
2018-12-05
Methods for treating myeloproliferative disorders
EP3261640A4
(en )
2018-12-19
5ht agonists for treating disorders
EP3166610A4
(en )
2017-11-29
Methods for treating neurologic disorders
EP3119911A4
(en )
2017-12-13
Methods for treating neurological disorders
EP3193865A4
(en )
2018-04-11
Methods for treating brain metastasis
EP3142664A4
(en )
2017-12-13
Compositions and methods for treating and diagnosing ocular disorders
EP3125908A4
(en )
2017-11-15
Compositions and methods for treating kidney disorders
EP3554505A4
(en )
2020-09-16
Methods of treating ocular disorders
EP3484515A4
(en )
2020-06-17
Methods for treating fibrosis
EP3368042A4
(en )
2019-06-26
Methods for treating epilepsy
EP3256117A4
(en )
2018-10-10
Methods for treating neuroblastoma
EP3240577A4
(en )
2018-07-25
Methods and compositions for treating brain diseases
EP3089748A4
(en )
2017-09-27
Treating ocular neovascularization
EP3310353A4
(en )
2019-02-06
Compositions and methods for treating and diagnosing ocular disorders
EP3209295A4
(en )
2018-05-23
Methods of treating ocular conditions
EP3194027A4
(en )
2018-04-18
Methods and compositions for treating psychotic disorders
PL3145511T3
(en )
2022-05-02
Composition for treating the eye
EP3262065A4
(en )
2018-08-01
Methods and compositions for treating dystroglycanopathy disorders
EP3244914A4
(en )
2018-08-15
Methods for treating tauopathy
EP3169684A4
(en )
2018-02-21
Methods and compositions for treating hiv-related disorders